MAXHEALTH

Max Healthcare Institute Share Price

₹1,010.25 -21.6 (-2.09%)

22 Feb, 2025 23:21

SIP TrendupStart SIP in MAXHEALTH

Start SIP

Performance

  • Low
  • ₹1,005
  • High
  • ₹1,039
  • 52 Week Low
  • ₹706
  • 52 Week High
  • ₹1,228
  • Open Price₹1,032
  • Previous Close₹1,032
  • Volume926,535

Investment Returns

  • Over 1 Month -6.3%
  • Over 3 Month + 2.03%
  • Over 6 Month + 16.46%
  • Over 1 Year + 18.29%
SIP Lightning

Smart Investing Starts Here Start SIP with Max Healthcare Institute for Steady Growth!

Invest Now

Max Healthcare Institute Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 97.4
  • PEG Ratio
  • -21.2
  • Market Cap Cr
  • 98,211
  • P/B Ratio
  • 11.2
  • Average True Range
  • 40.78
  • EPS
  • 10.91
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -16.64
  • RSI
  • 41.32
  • MFI
  • 29.01

Max Healthcare Institute Financials

Max Healthcare Institute Technicals

EMA & SMA

Current Price
₹1,010.25
-21.6 (-2.09%)
pointer
  • stock-down_img
  • Bullish Moving Average 3
  • stock-up_img
  • Bearish Moving Average 13
  • 20 Day
  • ₹1,051.97
  • 50 Day
  • ₹1,068.82
  • 100 Day
  • ₹1,045.82
  • 200 Day
  • ₹976.52

Resistance and Support

1018.12 Pivot Speed
  • R3 1,065.33
  • R2 1,052.22
  • R1 1,031.23
  • S1 997.13
  • S2 984.02
  • S3 963.03

What's your outlook on Max Healthcare Institute?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Max Healthcare Institute Ltd. is one of India’s leading healthcare providers, operating a network of multi-specialty hospitals. It offers comprehensive medical services across various specialties, including oncology, cardiology, and neurology, serving both domestic and international patients.

Max Healthcare Institute has an operating revenue of Rs. 6,541.62 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 25% is great, ROE of 12% is good. The company has a reasonable debt to equity of 13%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 6% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 72 which is a FAIR score but needs to improve its earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 19 indicates it belongs to a strong industry group of Medical-Hospitals and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Max Healthcare Institute Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-01-30 Quarterly Results
2024-11-05 Quarterly Results
2024-08-01 Quarterly Results
2024-05-22 Audited Results & Final Dividend
2024-01-31 Quarterly Results
Date Purpose Remarks
2024-08-23 FINAL Rs.1.50 per share(15%)Final Dividend
2023-09-08 FINAL Rs.1.00 per share(10%)Final Dividend

Max Healthcare Institute F&O

Max Healthcare Institute Shareholding Pattern

23.74%
11.72%
3.06%
56.93%
0%
3.13%
1.42%

About Max Healthcare Institute

  • NSE Symbol
  • MAXHEALTH
  • BSE Symbol
  • 543220
  • Chairman & Managing Director
  • Mr. Abhay Soi
  • ISIN
  • INE027H01010

Similar Stocks to Max Healthcare Institute

Max Healthcare Institute FAQs

Max Healthcare Institute share price is ₹1,010 As on 22 February, 2025 | 23:07

The Market Cap of Max Healthcare Institute is ₹98210.7 Cr As on 22 February, 2025 | 23:07

The P/E ratio of Max Healthcare Institute is 97.4 As on 22 February, 2025 | 23:07

The PB ratio of Max Healthcare Institute is 11.2 As on 22 February, 2025 | 23:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23